Ken Griffin’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$32.2M Buy
153,439
+56,076
+58% +$14.1M 0.01% 1785
2025
Q4
$27.7M Sell
97,363
-255,080
-72% -$79.8M ﹤0.01% 1994
2025
Q3
$109M Sell
352,443
-419,105
-54% -$131M 0.02% 780
2025
Q2
$242M Buy
771,548
+627,598
+436% +$181M 0.04% 345
2025
Q1
$37.8M Sell
143,950
-585,155
-80% -$158M 0.01% 1388
2024
Q4
$190M Sell
729,105
-261,384
-26% -$65.8M 0.03% 428
2024
Q3
$231M Sell
990,489
-517,322
-34% -$106M 0.04% 319
2024
Q2
$304M Sell
1,507,811
-160,681
-10% -$29M 0.06% 231
2024
Q1
$286M Buy
1,668,492
+337,098
+25% +$62.9M 0.06% 252
2023
Q4
$289M Sell
1,331,394
-68,437
-5% -$11.7M 0.06% 223
2023
Q3
$223M Buy
1,399,831
+1,094,792
+359% +$245M 0.05% 282
2023
Q2
$88M Buy
305,039
+253,091
+487% +$76.9M 0.02% 686
2023
Q1
$16.6M Sell
51,948
-4,307
-8% -$1.28M ﹤0.01% 2144
2022
Q4
$16.6M Buy
56,255
+37,177
+195% +$10.3M ﹤0.01% 2167
2022
Q3
$4.38M Buy
19,078
+18,037
+1,733% +$4.52M ﹤0.01% 4097
2022
Q2
$227K Sell
1,041
-78,312
-99% -$17.8M ﹤0.01% 10435
2022
Q1
$21.1M Buy
79,353
+19,805
+33% +$4.86M ﹤0.01% 1925
2021
Q4
$15.8M Buy
59,548
+45,830
+334% +$13.3M ﹤0.01% 2334
2021
Q3
$3.9M Sell
13,718
-292,116
-96% -$83.3M ﹤0.01% 4810
2021
Q2
$84M Sell
305,834
-341,960
-53% -$93M 0.02% 773
2021
Q1
$169M Buy
647,794
+222,826
+52% +$59.7M 0.04% 352
2020
Q4
$109M Buy
424,968
+182,942
+76% +$45.4M 0.03% 505
2020
Q3
$57.3M Sell
242,026
-209,982
-46% -$44.2M 0.02% 767
2020
Q2
$87.8M Buy
452,008
+15,851
+4% +$3.03M 0.03% 469
2020
Q1
$72.3M Buy
436,157
+198,335
+83% +$36.2M 0.03% 476
2019
Q4
$40.7M Buy
237,822
+137,924
+138% +$23M 0.02% 899
2019
Q3
$16.5M Sell
99,898
-511,202
-84% -$71.8M 0.01% 1672
2019
Q2
$73M Buy
611,100
+41,246
+7% +$4.23M 0.03% 537
2019
Q1
$54.2M Buy
569,854
+379,295
+199% +$32.5M 0.03% 649
2018
Q4
$15.1M Sell
190,559
-204,203
-52% -$17.3M 0.01% 1465
2018
Q3
$41.8M Sell
394,762
-51,960
-12% -$4.87M 0.02% 858
2018
Q2
$38.3M Buy
446,722
+423,470
+1,821% +$38M 0.02% 851
2018
Q1
$2.02M Sell
23,252
-8,851
-28% -$688K ﹤0.01% 3723
2017
Q4
$2.21M Buy
32,103
+21,720
+209% +$1.43M ﹤0.01% 3498
2017
Q3
$572K Sell
10,383
-176,132
-94% -$9.62M ﹤0.01% 5125
2017
Q2
$9.57M Buy
+186,515
New +$8.1M 0.01% 1496
2017
Q1
Sell
-31,744
Closed -$1.36M 7901
2016
Q4
$1.2M Buy
31,744
+4,961
+19% +$185K ﹤0.01% 3623
2016
Q3
$1.1M Sell
26,783
-5,134
-16% -$203K ﹤0.01% 3723
2016
Q2
$965K Buy
31,917
+25,605
+406% +$797K ﹤0.01% 3593
2016
Q1
$209K Sell
6,312
-25,630
-80% -$805K ﹤0.01% 5583
2015
Q4
$1.21M Buy
31,942
+23,706
+288% +$798K ﹤0.01% 3351
2015
Q3
$213K Sell
8,236
-185,769
-96% -$5.63M ﹤0.01% 6066
2015
Q2
$6.01M Buy
+194,005
New +$5.72M 0.01% 1891
2015
Q1
Sell
-14,464
Closed -$488K 8773
2014
Q4
$666K Buy
14,464
+11,790
+441% +$504K ﹤0.01% 4314
2014
Q3
$99K Buy
2,674
+2,259
+544% +$82.5K ﹤0.01% 6423
2014
Q2
$16K Sell
415
-51,251
-99% -$1.97M ﹤0.01% 7420
2014
Q1
$2.45M Buy
51,666
+165
+0.3% +$7.3K ﹤0.01% 2444
2013
Q4
$1.91M Buy
51,501
+49,212
+2,150% +$1.82M ﹤0.01% 2598
2013
Q3
$83K Sell
2,289
-1,538
-40% -$51.6K ﹤0.01% 5464
2013
Q2
$120K Buy
+3,827
New +$108K ﹤0.01% 5088

Other funds holding PODD

Ken Griffin's PODD Position: Q1 2026 in Review

Ken Griffin increased its Insulet (PODD) stake by 58% in Q1 2026, buying an estimated $14.1M and bringing the position to 153,439 shares worth $32.2M. The position accounts for 0.01% of the portfolio, ranked #1785.

Ken Griffin first reported a position in PODD in Q2 2013 and has held it in 50 quarters since. The position peaked at $304M in Q2 2024. 786 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • Ken Griffin held 153,439 shares of Insulet worth $32.2M as of Q1 2026.
  • Ken Griffin bought 56,076 Insulet shares in Q1 2026, an estimated $14.1M.
  • Insulet made up 0.01% of Ken Griffin's portfolio in Q1 2026, its #1785 holding.
  • Ken Griffin first reported a position in Insulet in Q2 2013 and has held it in 50 quarters since.
  • Ken Griffin's Insulet position peaked at $304M in Q2 2024.
  • 786 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.